IRF3 and melanoma: In addition, we confirmed the presence of IRF3 covalent dimers upon doxorubicin treatment also in Hela cells (Fig. S1A), thus suggesting that the TG2 posttranslational modification of IRF3 is not limited to melanoma cells.